Filing Details

Accession Number:
0001607062-17-000333
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-12 14:54:33
Reporting Period:
2017-10-11
Accepted Time:
2017-10-12 14:54:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1460602 Orgenesis Inc. ORGS Pharmaceutical Preparations (2834) 980583166
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1706479 Sca Theodorus Allee De La Recherche, 12
Anderlecht C9 1070
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-10-11 2,500,000 $0.25 2,952,358 No 4 S Direct
Common Stock Disposition 2017-10-11 2,500,000 $0.25 2,952,358 No 4 S Indirect I
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect I
Footnotes
  1. Theodorus SCA and Theodorus II SA entered into Restricted Stock Purchase Agreements with 5 individuals pursuant to which they each sold an aggregate of 2,500,000 shares of common stock (the "Purchase Agreements"). Under the Purchase Agreements, Theodorus SCA and Theodorus II SA each granted the purchasers an option to purchase a pro rate portion of a total of 5,904,715 shares of common stock for a 120 day period from the date of the respective Purchase Agreements ("Optioned Shares").
  2. Determined in accordance with Rule 13d-3(d)(1), as a result of their cooperation and acting in convert for the sole purpose of facilitating the orderly disposition of the Optioned Shares, Theodorus SCA and Theodorus II SA may be deemed to beneficially own as a group 5,904,716 shares of the Issuer's common stock. Monsieur Belenger is the investment manager for Theodorus SCA and Theodorus II SA and has sole voting and dispositive power of the shares beneficially owned by Theodorus SCA and Theodorus II SA. Theodorus SCA expressly disclaims beneficial ownership in the shares beneficially owned by Theodorus II SA.